ClinicalTrials.govpublic full text
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, type 2 diabetes mellitus, additional relevant mesh terms:, hypoglycemic agents, physiological effects of drugs, pharmacologic actions, pioglitazone, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827409
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.